Cardiorenal risk stratification in high-risk type 2 diabetes using a simple clinical score: findings from the ELIXA trial.

The combination of modest discriminative performance—reflected by the area under the receiver operating characteristic curve—and highly significant relative risks suggests that the model functions less as a classifier for a specific outcome and more as a robust tool for stratifying patients along a continuum of cardiorenal risk.

also in 132,142 other papers